Lara Sullivan - 07 Sep 2023 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
President and CEO, Director
Signature
/s/ Pamela Connealy, Attorney-in-Fact for Lara Sullivan
Issuer symbol
PYXS
Transactions as of
07 Sep 2023
Net transactions value
$0
Form type
4
Filing time
08 Sep 2023, 17:00:23 UTC
Previous filing
28 Mar 2023
Next filing
13 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PYXS Common Stock Award $0 +469,483 +22% $0.000000 2,625,182 07 Sep 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that are fully vested.